Dr. Jain attended the Molecular Med Tricon 2017 conference at San Francisco 19-23rd Februrary, 2017. It was a blend of academia and industry working in the field of personalized medicine using molecular approaches. Dr. Jain joined Sapien’s partner, Trans-Hit Bio of Canada, who had put up a booth at the conference and promoted our partnership jointly.
Dr. Jain attended the Diagnostics and Cancer Tracks where dozens of companies and groups working on improving the sensitivity and specificity of blood- or urine-based markers ranging from cancer cells or cell-free DNA, RNA, proteins presented new technologies. Such groups are potential customers of our biobank so it was a good meeting from business point of view as well.